Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb
WKN: 850501 / Symbol: BMY / Name: Bristol-Myers / Aktie / Pharmazeutika / Large Cap /
55,97 €
0,31 %
Bristol Myers Squibb (BMY) was upgraded by Argus from "hold" to "buy". They now have a $75.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
Bristol Myers Squibb (BMY) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
Bristol Myers Squibb (BMY) is now covered by TD Cowen. They set a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
Bristol Myers Squibb (BMY) is now covered by Roth Capital. They set a "buy" rating on the stock.
Ratings data for BMY provided by MarketBeat
Bristol Myers Squibb (BMY) was upgraded by Sanford C. Bernstein from "market perform" to "outperform".
Ratings data for BMY provided by MarketBeat
Bristol Myers Squibb (BMY) is now covered by Piper Sandler. They set an "overweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
Neueste Beiträge
TD_Cowen in Cogent Communications Hldg. Inc. diskutieren